Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04925193 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04925193
- Sponsor
- University of Colorado, Denver
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2024-08-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.